Clinical Trials Directory

Trials / Completed

CompletedNCT01644305

Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.

1. Association of Plasma GDF-9 or GDF-15 Levels With Bone Parameters in Polycystic Ovary Syndrome. 2. Plasma GDF-15 Levels and Their Association With Hormonal and Metabolic Status in Women With Polycystic Ovary Syndrome Aged 25-35.

Status
Completed
Phase
Study type
Observational
Enrollment
85 (actual)
Sponsor
Ankara Education and Research Hospital · Other Government
Sex
Female
Age
25 Years – 35 Years
Healthy volunteers

Summary

The purpose of this study is to determine the plasma levels of GDF-9 and GDF-15, and their association with bone and cardiovascular parameters in patients with Polycystic Ovary Syndrome.

Conditions

Timeline

Start date
2012-07-01
Primary completion
2013-07-01
Completion
2013-08-01
First posted
2012-07-19
Last updated
2018-06-27

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01644305. Inclusion in this directory is not an endorsement.

Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome. (NCT01644305) · Clinical Trials Directory